Safety and efficacy of early corticosteroid withdrawal in liver transplant recipients: A randomized controlled trial.
Jong Man KimJae Won JohKwang-Woong LeeDong Lak ChoiHee-Jung WangPublished in: Annals of hepato-biliary-pancreatic surgery (2024)
The present study did not find a significant reduction in the incidence of NODAT in the early steroid withdrawal group. Our study suggests that steroid withdrawal three months posttransplantation is a standard and safe immunosuppressive strategy for LT patients.